🔴 LIVE: The Secrets of ProPicks AI Success Revealed + November’s List FREEWatch Now

S&P 500 set to dip after vaccine news rally

Published 2020-11-10, 09:20 a/m
© Reuters. The U.S. flag covers the front facade of the NYSE in New York
NDX
-
LLY
-
AAPL
-
AMZN
-
AMGN
-
PFE
-
1YMZ24
-
NFLX
-
META
-

By Medha Singh and Shivani Kumaresan

(Reuters) - The S&P 500 was set to open lower on Tuesday as excitement over signs of a first successful late-stage COVID-19 vaccine trial faded, while investors continued to pull money out of the big tech companies that have benefitted most from the pandemic.

Technology-focused stocks, which have benefited from this year's work-from-home shift and powered Wall Street to new heights, were the odd ones out in a broad rally on Monday, and futures for the tech-heavy Nasdaq 100 were again down 1.5% in early trade.

Netflix Inc (NASDAQ:NFLX), Amazon.com Inc (NASDAQ:AMZN), Facebook Inc (NASDAQ:FB), and Apple Inc (NASDAQ:AAPL) fell between 1.8% and 2.3% as investors rotated into sectors that are expected to benefit from a full reopening of the economy such as travel, energy and financials, although the latter moves were muted compared to the previous day.

"The rotation could be different this time because.. it is predicated on the fact that we have evidence to say things will get better," said Art Hogan, chief market strategist at National Securities in New York.

The main U.S. indexes hit new peaks on Monday as data from Pfizer (NYSE:PFE)'s late-stage COVID-19 vaccine trial spurred bets of a swift economic recovery next year. Democrat Joe Biden's projected victory in the U.S. presidential election also added to the market cheer.

Biden hailed the progress on the vaccine, but urged caution saying it would be "many more months" before widespread vaccination is available. Meanwhile, daily new U.S. cases topped 100,000 for the sixth straight day.

U.S. regulators on Monday also authorized emergency use of the first experimental antibody drug for COVID-19 developed by Eli Lilly (NYSE:LLY) & Co, pushing its shares up by 3.4%.

At 08:23 a.m. ET, Dow futures were up 0.7%, led by a 4% jump for Amgen Inc (NASDAQ:AMGN) after its asthma drug, being developed in collaboration with AstraZeneca, met the main goal of a late-stage study.

S&P 500 E-minis were down 0.14%.

Shares of big U.S. banks, which are sensitive to the broader economic outlook, edged higher while cruise line operators and airlines battered by travel restrictions gained between 1% and 4.3%.

© Reuters. The U.S. flag covers the front facade of the NYSE in New York

One big set-piece on Tuesday will by an Apple event, expected to unveil new Mac computers using its own in-house processor chips.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.